These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2649351)

  • 1. [Principles of relapse therapy in acute myeloid leukemia].
    Hiddemann W; Büchner T; van de Loo J
    Dtsch Med Wochenschr; 1989 Apr; 114(15):599-605. PubMed ID: 2649351
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor buffy-coat infusion and chemotherapy for leukemia in relapse after marrow transplantation.
    Bogdanić V; Aurer I; Hitrec V; Boban D; Nemet D; Zupancić-Salek S; Labar B
    Haematologica; 1995; 80(4):338-40. PubMed ID: 7590504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous stem cell transplantation versus chemotherapy for adult patients with acute myeloid leukemia in first remission: the BGMT Group experience.
    Reiffers J; Stoppa AM; Attal M; Michallet M; Marit G; Blaise D; Huguet F; Corront B; Cony-Makhoul P; Montastruc M
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):17-9. PubMed ID: 8099731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approaches to the therapy of relapsed acute myeloid leukemia.
    Schiffer CA; Lee EJ
    Oncology (Williston Park); 1989 Aug; 3(8):23-7; discussion 28. PubMed ID: 2519195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP).
    Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G
    Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic marrow transplantation for acute non-lymphoblastic leukemia: first remission versus after first relapse.
    Buckner CD; Sanders J; Appelbaum FR
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():244-6. PubMed ID: 2653513
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French Society of Pediatric Hematology and Immunology.
    Aladjidi N; Auvrignon A; Leblanc T; Perel Y; Bénard A; Bordigoni P; Gandemer V; Thuret I; Dalle JH; Piguet C; Pautard B; Baruchel A; Leverger G;
    J Clin Oncol; 2003 Dec; 21(23):4377-85. PubMed ID: 14645428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The strategy for the therapy of acute myeloid leukemias in adults].
    Savchenko VG; Parovichnikova EN; Isaev VG; Kucher RA
    Ter Arkh; 1992; 64(7):4-17. PubMed ID: 1440365
    [No Abstract]   [Full Text] [Related]  

  • 10. Current options in the management of acute myeloid leukaemia.
    Kelsey SM; Newland AC
    QJM; 1995 Dec; 88(12):849-52. PubMed ID: 8593544
    [No Abstract]   [Full Text] [Related]  

  • 11. Transplantation of patients with high risk acute myeloid leukemia in first remission with autologous marrow cultured in interleukin-2 followed by interleukin-2 administration.
    Klingemann HG; Eaves CJ; Barnett MJ; Eaves AC; Hogge DE; Nantel SH; Reece E; Shepherd JD; Sutherland HJ; Phillips GL
    Bone Marrow Transplant; 1994 Sep; 14(3):389-96. PubMed ID: 7994260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose chemotherapy with busulfan, cyclophosphamide, and etoposide as conditioning regimen for allogeneic bone marrow transplantation for patients with acute myeloid leukemia in first complete remission.
    Zander AR; Berger C; Kröger N; Stockshläder M; Krüger W; Horstmann M; Grimm J; Zeller W; Kabisch H; Erttmann R; Schönrock P; Kuse R; Braumann D; Illiger HJ; Fiedler W; de Witt M; Hossfeld KD; Weh HJ
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2671-5. PubMed ID: 10068272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT).
    Gorin NC; Labopin M; Fouillard L; Meloni G; Frassoni F; Iriondo A; Brunet Mauri S; Goldstone AH; Harousseau JL; Reiffers J; Esperou-Bourdeau H; Gluckman E
    Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone marrow transplantation in the treatment of acute leukemias].
    Moiseev SI; Ganapiev AA; Abdulkadyrov KM
    Ter Arkh; 1996; 68(12):8-10. PubMed ID: 9054052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation.
    de la Rubia J; Sanz GF; Martín G; Sempere A; Picón I; Carral A; Larrea L; Martínez J; Soler MA; Bonanad S; López F; Jarque I; Sanz MA
    Bone Marrow Transplant; 1996 Dec; 18(6):1167-73. PubMed ID: 8971390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission.
    Singhal S; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Mehta J
    Bone Marrow Transplant; 1996 Apr; 17(4):637-41. PubMed ID: 8722368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Special clinical concerns/problems in the management of MDS and secondary acute myeloid leukemias.
    Venugopal P; Manson S; Preisler HD
    Cancer Treat Res; 2001; 108():257-65. PubMed ID: 11702603
    [No Abstract]   [Full Text] [Related]  

  • 18. Single-institution results of autologous bone marrow transplantation in acute myeloid leukemia.
    Lambertenghi Deliliers G; Annaloro C; Della Volpe A; Oriani A; Mozzana R; Pozzoli E; Tagliaferri E; Soligo D
    Haematologica; 1995; 80(2):136-41. PubMed ID: 7628752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Maintenance of remission in acute myeloid leukemia by allogeneic or autologous bone marrow transplantation].
    Beelen DW; Quabeck K; Mahmoud HK; Sayer HG; Kraft J; Graeven U; Grosse-Wilde H; Quast U; Schaefer UW
    Dtsch Med Wochenschr; 1991 Mar; 116(11):401-10. PubMed ID: 2001649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.
    Stone RM; Mayer RJ
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):47-64. PubMed ID: 8449864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.